Conceptio › Archive › IRIS
IRIS metadata only

Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the I-STOP study

Gemelli, Maria et al.
IRIS · Papers
Open Source ↗
immune-check-point-inhibitornon-small-cell-lung-cancer
Background The optimal duration of immune checkpoint inhibitors (ICIs) in advanced non-small cell lung cancer (NSCLC) remains undefined. While most trials adopt a 2-year treatment cap, evidence supporting this strategy in real-world practice is limited. The I-STOP study evaluated outcomes of patient
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1053674
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive